chartexchange

XGN
Exagen Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:53 PM EDT
8.16USD+3.422%(+0.27)617,367
Loading…
Loading…
197.92M
Healthcare
Diagnostics & Research
HQ
Vista, CA, USA
Previous Close
$7.89
Beta
2.26
52-Week High
$12.23 2025-10-27
52-Week Low
$2.59 2026-03-30
SMA 50
$7.09
SMA 200
$4.83
Avg. Vol 10D
331,609
Avg. Vol 30D
273,055
Avg. Vol 90D
327,473
Relative Vol
2.26
13.81M
0.5600%
4,100,000
Nov 3, 2026 (29d)
XGN Profile

exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.

XGN Performance
PeriodPriceDateChangeBeta
1W8.482026-09-28-3.66%5.780
1M7.582026-09-04+7.78%1.442
3M4.402026-07-06+85.68%3.621
6M3.082026-04-06+165.26%2.749
1Y10.962025-10-03-25.46%2.259
2Y3.002024-10-04+172.33%—
5Y13.392021-10-04-38.98%1.176
XGN Stock Summary

Exagen Inc. Common Stock (NASDAQ:XGN) stock price today is $8.17, and today's volume is 617,367. XGN is up 3.549% today. The 30 day average volume is 273,055. XGN market cap is $197.92M with 24.23M shares outstanding.